AlphAIAlphAI — Financial news for AI agents
investing.com$PLMR

Palomar earnings beat by $0.46, revenue topped estimates

Palomar (PLMR) reported Q3 EPS of $3.01, beating estimates by $0.46, with revenue of $767M, exceeding expectations. The stock is up 9.95% in 3 months and 23.42% in 12 months. InvestingPro rates its financial health as 'great performance'.

Original reporting
investing.com
Published Nov 4, 2026, 10:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 10:40 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$PLMR
Bullish
high confidence
Mentioned
$PLMR
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$PLMRBullishHigh
01

Why it matters

Earnings beat is the primary catalyst; no other material news is presented.

02

Market read

First‑report earnings beat for a mid‑cap biotech, offering a short‑term trading opportunity.

03

What to watch

No guidance update was provided; future revenue growth remains uncertain.

Relevance 7/10Novelty 8/10Timing: post‑market today

Background

The article is a straightforward earnings recap from Investing.com with no additional analysis.

Company-level read

Ticker impact

$PLMRBullishHigh confidence
Context

Palomar reported Q3 EPS of $3.01, beating estimates by $0.46 and revenue of $767M versus $754.6M expectations.

Expected impact

likely upward pressure as investors price in the earnings beat.

Evidence & confidence

The beat is material for a mid‑cap biotech; the surprise magnitude and fresh guidance can move the stock in the next trading session.

Market effects

Sector

Positive earnings may lift peer biotech stocks and reinforce sector momentum.

Regional

Limited to US biotech market; no broader regional effect.

Global

Minimal global impact beyond sector peers.

Counterpoint

What could challenge this read

If the beat is already priced in, the stock could face profit‑taking pressure.

Key entities

  • company
    Palomar

    Biotech firm reporting Q3 results.

Read at source← All news

StoryPalomar reports record Q3 results and raises full-year profit guidance

Also covered by

3 outlets

Related articles

$PLMRHighAI 8/10

Palomar Holdings, Inc. (PLMR): Investor Presentation November 2026

Palomar Holdings, Inc. (PLMR) filed an SEC Form 8-K — Regulation FD Disclosure. Investor Presentation November 2026 Disclaimer This presentation contains forward-looking statements about Palomar Holdings, Inc. (the “Company”). These statements involve known and unknown risks that relate to the Company’s future events or future financial performance and the a

SEC EDGAR 8-K
$PLMRHigh

Keefe Bruyette raises Palomar Holdings stock price target on earnings beat

Keefe Bruyette & Woods raised its price target for Palomar Holdings (PLMR) to $172 from $161, citing strong Q3 2026 earnings and updated financial estimates. The firm expects lower core loss ratios and faster net investment income growth. PLMR reported adjusted EPS of $3.01, beating estimates, and raised its full-year adjusted net income guidance. Truist Securities also increased its price target to $175.

investing.com
$PLMRMed

Palomar Q3 Earnings Call Highlights

Palomar (PLMR) reported Q3 earnings, with CFO Chris Uchida noting $425M in crop premiums and confidence in reaching a $500M intermediate goal. CEO Armstrong highlighted growth in earthquake, inland marine, and property premiums, despite commercial rate pressure. The company's adjusted combined ratio was 76.3%, up from 74.8% YoY, with a total loss ratio of 41.5%. Palomar expects continued growth and capital returns, including dividends and stock repurchases.

finance.yahoo.com
$PLMRHighAI 8/10

Palomar Holdings Inc (PLMR) (Q3 2026) Earnings Call Highlights: Record Premium, 16th

Palomar Holdings Inc (PLMR) reported record Q3 2026 results with gross written premium up 28% YoY and adjusted net income of $81.3M. Adjusted EPS grew 50%, and the combined ratio was 76%. All product categories grew, with crop and surety leading. Guidance was raised to $280M-$285M for full-year adjusted net income. Challenges include decelerated casualty growth and catastrophe losses.

finance.yahoo.com
$PLMRMed

Truist raises Palomar Holdings stock price target on earnings growth

Truist Securities raised its price target on Palomar Holdings (PLMR) to $175 from $168, citing earnings growth and strong fundamentals. The stock trades at $153.07 with a market cap of $4.04B. Truist also increased its 2026 and 2027 EPS estimates, noting revenue growth of 58% and a 23% return on equity. Palomar reported Q3 2026 earnings of $3.01 per share, beating estimates.

investing.com